Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Peer Christiansen"'
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Vibeke Jensen, Peer Christiansen, Giedrius Lelkaitis, Sarah Schulz Nielsen, Marianne Djernes Lautrup, Anne Marie Bak Jylling
Publikováno v:
Breast Cancer (Tokyo, Japan)
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Background To describe relevant pathological parameters of Danish male breast cancer patients (MBCP) diagnosed from 1980 to 2009, and to relate these data to treatment, overall survival (OS) and standardized mortality rate (SMR). Materials and method
Autor:
Trine Tramm, Peer Christiansen, Anne Bodilsen, Hanne Melgaard Nielsen, Jonas Amstrup Funder, Anne Schmidt Sorensen, Marco Mele, Josephine Bruun
Publikováno v:
Mele, M, Sørensen, A S, Bruun, J, Funder, J A, Tramm, T, Bodilsen, A, Nielsen, H M & Christiansen, P M 2019, ' Inflammatory breast cancer : A review from our experience ', Breast Disease, vol. 38, no. 2, pp. 47-55 . https://doi.org/10.3233/BD-180365
INTRODUCTION: Inflammatory Breast Cancer (IBC) is a distinct and rare type of breast cancer accounting for up to 6% of all breast cancer cases in Europe. The aim of this study was to investigate diagnostic methods, treatments, and outcome after IBC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2fde238c6e05cc881054e1f438ab79
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
Autor:
Tinne Laurberg, Christina D Lyngholm, Peer Christiansen, Tine Engberg Damsgaard, Jan Alsner, Jens Overgaard
Publikováno v:
Lyngholm, C D, Laurberg, T, Alsner, J, Damsgaard, T E, Overgaard, J & Christiansen, P 2016, ' Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort ', Acta Oncologica, vol. 55, no. 8, pp. 983-992 . https://doi.org/10.3109/0284186X.2016.1156741
Based on the results from the DBCG 82 trial, breast conserving therapy (BCT) has been implemented as standard in Denmark since 1989, and today constitutes more than 70% of the primary treatment. Our aim was to evaluate the implementation of BCT as a
Autor:
Jens Overgaard, Peer Christiansen, Bent Ejlertsen, Nikolaj Amby, Anne Bodilsen, Pernille Vahl, J Michael Dixon, Birgitte Vrou Offersen, Karsten Bjerre
Publikováno v:
Journal of Surgical Oncology. 113:609-615
Background and Method The association between margin width and ipsilateral breast tumour recurrence (IBTR, defined as invasive recurrence) was investigated in a population-based nationwide cohort of 11,900 patients undergoing breast-conserving therap
Autor:
Karen Haugaard, Susanne Bokmand, Signe S. Thorup, Peer Christiansen, Hjoerdis Joernsgaard, Giedrius Lelkaitis, Marianne Djernes Lautrup, Gro M. Qvamme, Vibeke Jensen, Mette H. Oldenburg, Anne Marie Bak Jylling, Katrine Soee, Inger Hoejris
Publikováno v:
Lautrup, M D, Thorup, S S, Jensen, V, Brokmand, S, Haugaard, K, Hoejris, I, Jylling, A-M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer: a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A-M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A-M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
OBJECTIVE: Describe prognostic parameters of Danish male breast cancer patients (MBCP) diagnosed from 1980-2009. Determine all-cause mortality compared to the general male population and analyze survival/mortality compared with Danish female breast c
Autor:
Gitte Bjørn Hvilsom, Christoffer Holst Hahn, Katalin Kiss, Henrik Baymler Pedersen, Christian Godballe, Stefano Christian Londero, Marie Louise Jespersen, Giedrius Lelkaitis, Sten Schytte, Peer Christiansen, Stine Rosenkilde Larsen
Publikováno v:
Hvilsom, G B, Londero, S C, Hahn, C H, Schytte, S, Pedersen, H B, Christiansen, P, Kiss, K, Larsen, S R, Jespersen, M L, Lelkaitis, G & Godballe, C 2018, ' Anaplastic thyroid carcinoma in Denmark 1996-2012 : A national prospective study of 219 patients ', Cancer epidemiology, vol. 53, pp. 65-71 . https://doi.org/10.1016/j.canep.2018.01.011
Hvilsom, G B, Londero, S C, Hahn, C H, Schytte, S, Pedersen, H B, Christiansen, P, Kiss, K, Larsen, S R, Jespersen, M L, Lelkaitis, G & Godballe, C 2018, ' Anaplastic thyroid carcinoma in Denmark 1996-2012 : A national prospective study of 219 patients ', Cancer Epidemiology, vol. 53, pp. 65-71 . https://doi.org/10.1016/j.canep.2018.01.011
Hvilsom, G B, Londero, S C, Hahn, C H, Schytte, S, Pedersen, H B, Christiansen, P, Kiss, K, Larsen, S R, Jespersen, M L, Lelkaitis, G & Godballe, C 2018, ' Anaplastic thyroid carcinoma in Denmark 1996-2012 : A national prospective study of 219 patients ', Cancer Epidemiology, vol. 53, pp. 65-71 . https://doi.org/10.1016/j.canep.2018.01.011
BACKGROUND: Anaplastic thyroid carcinoma (ATC) is the least common but most malignant thyroid cancer. We aimed to examine the characteristics as well as evaluate the incidence, prognostic factors, and if introduction of a fast track cancer program mi
Autor:
Stephen Hamilton-Dutoit, Anders Kjærsgaard, Peer Christiansen, Marianne Ewertz, Rebecca A. Silliman, Henrik Toft Sørensen, Marco Mele, Deirdre Cronin-Fenton, Timothy L. Lash, Bent Ejlertsen, Thomas P. Ahern
Publikováno v:
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 59, no. 6, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
BACKGROUND: Validation studies of the Danish Breast Cancer Group (DBCG) registry show good agreement with medical records for adjuvant treatment data, but inconsistent recurrence information. No studies have validated changes in menopausal status or
Autor:
Deirdre P. Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L. Lash, Henrik Toft Sørensen, Thomas P. Ahern, Per Damkier, Rebecca A. Silliman
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805, pp. e021805 . https://doi.org/10.1136/bmjopen-2018-021805
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
PurposeThe Predictors of Breast Cancer Recurrence (ProBe CaRe) study was established to evaluate modification of tamoxifen (TAM) effectiveness in premenopausal women through reduced activity of TAM-metabolising enzymes. It comprehensively evaluates t
Autor:
Anders Husted Madsen, Jens Peter Garne, S. Cold, Peer Christiansen, Marianne Ewertz, Anni Ravnsbæk Jensen, Jens Overgaard
Publikováno v:
Madsen, A H, Jensen, A R, Christiansen, P, Garne, J P, Cold, S, Ewertz, M & Overgaard, J 2008, ' Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group ', Acta Oncologica, vol. 47, no. 2, pp. 239-247 . https://doi.org/10.1080/02841860701727436
Madsen, A H, Jensen, A R, Christiansen, P, Garne, J P, Cold, S, Ewertz, M & Overgaard, J 2008, ' Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group ', Acta Oncologica, vol. 47, no. 2, pp. 239-47 . https://doi.org/10.1080/02841860701727436
Madsen, A H, Jensen, A R, Christiansen, P, Garne, J P, Cold, S, Ewertz, M & Overgaard, J 2008, ' Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group ', Acta Oncologica, vol. 47, no. 2, pp. 239-47 . https://doi.org/10.1080/02841860701727436
Udgivelsesdato: 2008-null BACKGROUND: The validation series of sentinel lymph node biopsy (SLNB) in the treatment of breast cancer have shown that 10-20% more lymph node metastases are detected. However, their impact has never been studied in populat